COMMUNIQUÉS West-GlobeNewswire

Silk Road Medical Announces Pricing of Initial Public Offering
04/04/2019
SUNNYVALE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq:SILK) (“Silk Road Medical”) today announced the pricing of its initial public offering of 6,000,000 shares of common stock at a [...]
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in China
04/04/2019
LA JOLLA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
ReWalk Robotics Announces Pricing of Registered Direct Offering for $4,250,000
04/04/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with [...]
Emerald Health Therapeutics signe une lettre d'intention pour la fourniture de cannabis au marché québecois
04/04/2019
VANCOUVER, Colombie-Britannique, 03 avr. 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV: EMH; OTCQX: EMHTF) a signé une lettre d'intention pour la fourniture de cannabis à la Société [...]
Harvard Bioscience Subsidiary Data Sciences International Wins Award for Best Achievement of Operational Excellence in Pharmaceuticals & Life Sciences
03/04/2019
Company Receives Honor at Business Transformation & Operational Excellence Industry Awards 2019 in Orlando, Florida HOLLISTON, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a division [...]
Progenics Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference
03/04/2019
NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, [...]
Progenics Pharmaceuticals Announces Presentations at the 2019 American Urological Association (AUA) Annual Meeting
03/04/2019
Results from Phase 2/3 OSPREY Trial of PyL in Prostate Cancer Selected for an Oral Presentation NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing [...]
Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock
03/04/2019
HAIFA, Israel, April 03, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI, TASE: PLTR) (“Pluristem” or “Company”), a leading regenerative medicine company developing novel placenta-based cell therapy [...]
Allogene Therapeutics Announces April 2019 Investor Conference Schedule
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies [...]
MacroGenics Reports Presentation of Data at the AACR Annual Meeting 2019
03/04/2019
ROCKVILLE, MD, April 03, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Flexion Therapeutics to Present at the 18th Annual Needham & Company Healthcare Conference
03/04/2019
BURLINGTON, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led [...]
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c)(4)
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]
Rubius Therapeutics to Participate in Jefferies 6th Annual IO Cell Therapy Summit
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
InspireMD, Inc. Announces Proposed Public Offering of Common Stock
03/04/2019
TEL AVIV, Israel, April 03, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery [...]
Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance
03/04/2019
Implements Plan to Reduce Acute Care Segment Staff CDMO Segment Continues Strong Performance; Company Increases Revenue, Operating Income and EBITDA, as Adjusted* Guidance for 2019 Expects to Become Cash Flow Breakeven [...]
DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares
03/04/2019
Montrouge, France, April 3, 2019 DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares DBV Technologies (the “Company”) (Euronext [...]
DBV Technologies annonce le lancement d’une offre globale d’actions ordinaires, pouvant prendre la forme d’American Depositary Shares
03/04/2019
Montrouge, France, le 3 avril (22h00 CEST) 2019 DBV Technologies annonce le lancement d’une offre globale d’actions ordinaires, pouvant prendre la forme d’American Depositary Shares DBV Technologies (la « Société ») ( [...]
Cidara Therapeutics to Present at the 18th Annual Needham Healthcare Conference
03/04/2019
SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Jeffrey Stein, Ph.D., [...]
Genocea to Present at 18th Annual Needham Healthcare Conference
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president and [...]

Pages